No case without histological confirmation has been included. The information required for the dead children was obtained from the hospital notes, while for most of the surviving children the general practitioners interviewed the mothers and loaned to us the relevant hospital letters. Consultants were asked to supply the necessary details for the remainder. On checking the records against the death certificates the inaccuracy of the latter was found to be about 8 %. Nineteen cases certified as Wilms's tumour had to be discarded-two-thirds because the necropsy findings did not confirm the death certificate diagnosis, and one-third on account of copying errors owing to the similarity of the words "neuroblastoma" and "nephroblastoma."
Introduction
For some years the Oxford Survey of Childhood Cancers has been collecting data on all cases of children certified as dying from cancer and also cases notified to registries in England and Wales who have survived. These data have made it possible to study individual diseases, first from the point of view of their natural history, and, secondly, in order to assess the effectiveness of different treatments. The present study, which is probably unique in that every case, including untreated and coroners' cases, is included, is based on 335 cases of Wilms's tumour, and is thought to comprise all the children in England and Wales under the age of 10 years who were diagnosed during the five-year period 1962-6. No case without histological confirmation has been included. The information required for the dead children was obtained from the hospital notes, while for most of the surviving children the general practitioners interviewed the mothers and loaned to us the relevant hospital letters. Consultants were asked to supply the necessary details for the remainder. On checking the records against the death certificates the inaccuracy of the latter was found to be about 8 %. Nineteen cases certified as Wilms's tumour had to be discarded-two-thirds because the necropsy findings did not confirm the death certificate diagnosis, and one-third on account of copying errors owing to the similarity of the words "neuroblastoma" and "nephroblastoma." leukaemia during this period, a figure which is similar to those published from Great Ormond Street (Riches, 1964) , Manchester (Pearson and Steward, 1969) , and the California Tumour Registry (Platt and Linden, 1964 ).
There were more boys than girls (184 boys, 151 girls; ratio 1-2: 1) ( Fig. 1 ) and more left-sided than right-sided tumours (185 left, 139 right; ratio 1-3:1; also nine bilateral cases). A significant excess of left-sided tumours was found at the 2% level and was confined to cases without extrarenal spread. Half of the tumours presented before the age of 3 years, the peak incidence being at 18 months. The total sample could be divided into three almost equal age groups, 119 under 2 years at diagnosis, 115 aged 2 or 3, and 100 over 4 years (no record of one). These figures are similar to those in other published series (Collins, 1955; Young and Williams, 1969) . The Registrar General's figures for deaths from Wilms's tumour in children under 10 for the period 1940-68 showed only a slight preponderance of boys, 876 male deaths as compared with 850 female deaths. This is a lower sex ratio than that found in our series; the period covered by the present study is atypical in this respect.
The modal age of cases arising spontaneously is consistent with Stewart and Kneale's (1970) finding that for tumours which were probably caused by obstetric radiography, and therefore initiated during the third trimester (radiogenic cases), the commonest latent period or interval from initiation to the onset of symptoms was 12 to 36 months.
Congenital tumours occurred in 10 children, six of whom have survived for three years or more without developing signs of further disease. All 10 underwent nephrectomy, and the four deaths occurred within the first month with no evidence of spread beyond the primary site. The absence of metastases in any of this group, together with the unusually high survival rate, raises the possibility that the tumours were fetal mesenchymal hamartomas (Wigger, 1969) .
The nine bilateral cases have been classified in a way modified from that suggested by Scott (1955) The incidence of congenital defects was similar to that already described by Barber and Spiers (1964) . The defects found in the present series are summarized in Table I . Aniridia occurred in one child only (cf. an incidence of 1:73 reported by Miller (1968) for children with Wilms's tumours). She was a mentally retarded child with bilateral aniridia and lens opacities. The nephroblastoma, diagnosed at the age of 10 months, was treated by nephrectomy, but the patient died four months later.
History and Presenting Symptoms
The duration of symptoms was known in 207 of the fatal cases and in 83 of the survivors. One-third of the whole series were admitted within a week and two-thirds within a month. No correlation between the length of history and the extent of the disease was found.
Among the 98 cases (one-third of the whole) with symptoms lasting a month or more before treatment was instituted a delay of up to four weeks occurred in 18 cases after a doctor had been consulted before laparotomy was done. Eleven of these presented with haematuria and were kept under observation as probably having acute nephritis; one was found to have a duplex kidney and not investigated further; and the other six were given provisional diagnoses of "enlarged spleen" (three cases), convulsions, obscure abdominal pain, and umbilical hernia. The 
Recurrence of Tumour
The term "recurrence" will be taken to mean a reappearance of neoplastic tissue either locally or outside the abdomen after removal of the primary tumour. Two hundred and thirty-two children thought to be tumour-free after nephrectomy have been followed up until death or for a survival period usually exceeding three years. The interval to recurrence or last follow-up is plotted against age at diagnosis for these children (Fig 2) . A recurrence was observed in 156 cases (67%), of whom 141 have died (three of them after surviving three years). The three-year survival rate for these cases was 12%. No recurrence has been observed in 76 cases, all of whom have survived.
The length of the so-called "period of risk"-that is, the period beyond which recurrence of the disease is unlikelyhas been discussed by many authors, including Collins et al. (1956) and Platt and Linden (1964) . Collins suggested that the period of risk was the age of the child plus nine months, on the grounds that the original tumour probably started close to the time of conception and any recurrence might be expected to have the same growth rate. In Fig. 2 the period of risk postulated by this rule is marked off by the diagonal line. If, however, it is postulated that the period of risk is usually two years, irrespective of the age of the child, the period is delimited by the horizontal line. In four cases the interval to recurrence exceeded the period given by the latter rule; of these, three occurred within 28 months of diagnosis. Two of the four also exceeded the period given by Collins, but since both had bilateral tumouxs it is probable that these "recurrences" were in fact new tumours. One child, after a nephrec- (c) Metastases in multiple sites were found in 46 cases, all of which were fatal.
Varying and unpredictable combinations of sites occurred, though in more than half the cases the sites involved were lungs and intra-abdominal structures, including the liver. In two cases a bone metastasis (skull and zygoma) was the first sign of reappearance of active disease, but in these and in all other cases with bony deposits other organs were subsequently affected. Bones involved were ribs, pelvis, spine, skull, and zygoma. Two children born with hydrocephalus died within the first year and were found to have Wilms's tumours with intracranial deposits.
Prognostic Factors
Of the total of 335 cases, 107 (32%) were alive three years after diagnosis. (The four surviving cases with periods of follow-up between 30 and 35 months have been counted as three-year survivors.) The survival curve for intervals up to three years-that is, the proportion of cases still alive at each time-is shown in Fig. 5 No.
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No. Possibly some of the successes in cases treated with actinomycin are in fact due to other aspects of the treatment they received. For example, among stage A and B cases in which a recurrence was observed 14 out of 28 (50%) had surgery for the recurrence, whereas for cases not initially given chemotherapy the corresponding figure was only 4 out of 46 (9%). On the other hand, the explanation of this difference might be that metastases occurring in actinomycin-treated cases are more amenable to surgical treatment. Again, the (standardized) survival rate for teaching and children's hospitals is considerably better than that for other hospitals for cases treated with actinomycin and rather better for cases not so treated. It may be that actinomycin was used in more effective dosages in the former.
Rates of recurrence are consistent with reports that actinomycin has an inhibiting effect on metastatic growth, but our results could easily be attributed to chance.
Treatment to Metastases
Eighteen children in whom metastases were detected after the initial treatment were still alive three years after the original diagnosis (three of these subsequently died). Three additional cases with metastases at the time of diagnosis have also survived. The results shown in Table VIII 
Discussion
Recent papers on the treatment of Wilms's tumour have presented apparently conflicting evidence on the efficacy of actinomycin. Several papers have presented series in which the proportion of successes, usually defined as survival for two years, is greater for cases treated with actinomycin than for cases not given the drug. These rates range from 67 to 92% (Howard, 1965; Farber, 1966; Fernbach and Martyn, 1966; Burgert and Glidewell, 1967) . Other authors quote rates from 29 to 63 % and state that these are similar to those for their comparison series not given actinomycin (Sukarochana and Kiesewetter, 1966; Maier and Harshaw, 1967; Stone and Williams, 1969) .
In the present series the overall three-year survival rate for cases treated with actinomycin was 38%. Three possible explanations for these conflicting reports should be considered: (a) differences in selection of cases, (b) the effects of other components of the treatment, and (c) differences in dose regimens.
(a) Not all assessments of actinomycin have made proper allowance for factors of known prognostic significance. We feel that the weight of evidence from the papers cited is that actinomycin does improve prognosis, but the information available in published series is usually inadequate for rigorous analyses to be made and varying degrees of case selection may have occurred. (c) Burgert and Glidewell (1967) suggested that better results are obtained if treatment with actinomycin is begun at the time of operation rather than later, but it is not clear that the groups of cases on which they base this conclusion are comparable. It has also been suggested that results are improved by giving repeated courses. The best evidence for this is provided by Wolff et al. (1968) , who found a statistically significant reduction in metastases when comparing this type of therapy against a single course in a controlled trial.
Actinomycin did not become generally available in this country until 1965, and it may be that its value cannot be properly assessed until more evidence has been accumulated on cases in which adequate dosage regimens have been used.
The present series includes 34 children who received actinomycin as part of their initial treatment in 1966. One child received two courses and the others one course only. The injections were started before operation in nine cases, at operation in seven, and postoperatively in 15 (for three cases no records are available).
We conclude that each of the factors (a), (b), and (c) may be contributing towards the different success rates quoted for actinomycin and that, in particular, the relatively disappointing results in the present series could be due to the fact that the cases were completely unselected and possibly that optimum drug schedules were not used. It would appear that, even admitting the practical difficulties, these questions can be elucidated only by carrying out a controlled trial, in which other drugs, such as vincristine, might also be included. The evidence in favour of actinomycin is such that it seems ethically impossible to withhold it at this stage, but we suggest that further trials similar to that of Wolff et al. (1968) should be carried out to evaluate various different drug schedules, with a sufficiently long follow-up to ensure that recurrences are being prevented and not simply postponed. 
